These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35676168)

  • 1. The Significance of Lymph Node Ratio and Total Lymph Nodes Examined in Determining the Indications of Adjuvant Radiation in pN2 Non-small Cell Lung Cancer.
    Zhu F; Wang H; Ashamalla H
    Clin Lung Cancer; 2022 Sep; 23(6):e384-e393. PubMed ID: 35676168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning to refine prognostic and predictive nodal burden thresholds for post-operative radiotherapy in completely resected stage III-N2 non-small cell lung cancer.
    Zarinshenas R; Ladbury C; McGee H; Raz D; Erhunmwunsee L; Pathak R; Glaser S; Salgia R; Williams T; Amini A
    Radiother Oncol; 2022 Aug; 173():10-18. PubMed ID: 35618098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.
    Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K
    Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Proposal for Combination of Lymph Node Ratio and Anatomic Location of Involved Lymph Nodes for Nodal Classification in Non-Small Cell Lung Cancer.
    Ding X; Hui Z; Dai H; Fan C; Men Y; Ji W; Liang J; Lv J; Zhou Z; Feng Q; Xiao Z; Chen D; Zhang H; Yin W; Lu N; He J; Wang L
    J Thorac Oncol; 2016 Sep; 11(9):1565-73. PubMed ID: 27223457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal adjuvant therapy in clinically N2 non-small cell lung cancer patients undergoing neoadjuvant chemotherapy and surgery: The importance of pathological response and lymph node ratio.
    Shinde A; Horne ZD; Li R; Glaser S; Massarelli E; Koczywas M; Erhunmwunsee L; Reckamp KL; Weksler B; Salgia R; Beriwal S; Amini A
    Lung Cancer; 2019 Jul; 133():136-143. PubMed ID: 31200820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncertain resection of highest mediastinal lymph node positive among pN2 non-small cell lung cancer patients: survival analysis of postoperative radiotherapy and driver gene mutations.
    Deng Q; Wang H; Xiu W; Tian X; Gong Y
    Jpn J Radiol; 2023 May; 41(5):551-560. PubMed ID: 36484979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative radiotherapy option based on mediastinal lymph node reclassification for patients with pN2 non-small-cell lung cancer.
    Jin J; Xu Y; Hu X; Chen M; Fang M; Hang Q; Chen M
    Curr Oncol; 2020 Jun; 27(3):e283-e293. PubMed ID: 32669935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node ratio precisely predicts the benefit of postoperative radiotherapy in esophageal cancer: A retrospective cohort study.
    Liang Y; Jian Q; Deng MG; Yi Z; Peng C; Lu C; Yang H; Liu J
    Asian J Surg; 2023 Sep; 46(9):3680-3686. PubMed ID: 37059676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediastinal downstaging after induction treatment is not a significant prognostic factor to select patients who would benefit from surgery: the clinical value of the lymph node ratio.
    Renaud S; Falcoz PE; Olland A; Reeb J; Santelmo N; Massard G
    Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):222-7. PubMed ID: 25413781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base.
    Mikell JL; Gillespie TW; Hall WA; Nickleach DC; Liu Y; Lipscomb J; Ramalingam SS; Rajpara RS; Force SD; Fernandez FG; Owonikoko TK; Pillai RN; Khuri FR; Curran WJ; Higgins KA
    J Thorac Oncol; 2015 Mar; 10(3):462-71. PubMed ID: 25384064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer.
    Urban D; Bar J; Solomon B; Ball D
    J Thorac Oncol; 2013 Jul; 8(7):940-6. PubMed ID: 23695418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study on the effects of neoadjuvant chemotherapy on lymph node ratio, prognosis, and survival analysis of stage ⅢA-N2 non-small cell lung cancer].
    Wei YL; Cui YH; Dong YH; Shi WJ
    Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(4):259-264. PubMed ID: 33486934
    [No Abstract]   [Full Text] [Related]  

  • 13. The Role of Postoperative Radiation Therapy for pN2 Non-small-cell Lung Cancer.
    Mankuzhy NP; Almahariq MF; Siddiqui ZA; Thompson AB; Grills IS; Guerrero TM; Lee KC; Stevens CW; Quinn TJ
    Clin Lung Cancer; 2021 Jan; 22(1):e5-e17. PubMed ID: 32873482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node ratio relationship to regional failure and distant metastases in oral cavity cancer.
    Hosni A; McMullen C; Huang SH; Xu W; Su J; Bayley A; Bratman SV; Cho J; Giuliani M; Kim J; Ringash J; Waldron J; Spreafico A; Weinreb I; de Almeida JR; Brown DH; Irish JC; O'Sullivan B; Goldstein DP; Hope A
    Radiother Oncol; 2017 Aug; 124(2):225-231. PubMed ID: 28838425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
    Qiu C; Dong W; Su B; Liu Q; Du J
    J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node ratio-dependent prognosis stratification and postoperative radiotherapy utilization in T1-2N1 oral cavity carcinoma.
    Wang J; Liu Y; Shayan G; Ma Y; Yi J
    Radiother Oncol; 2022 Jul; 172():83-90. PubMed ID: 35568286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of lymph node ratio in patients with surgically resected stage I-III small-cell lung cancer: a propensity score matching analysis of the SEER database.
    Yang H; Mei T
    Eur J Cardiothorac Surg; 2021 Nov; 60(5):1212-1220. PubMed ID: 34195790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of the metastatic lymph node ratio for predicting the prognosis of non-small-cell lung cancer patients.
    Wang CL; Li Y; Yue DS; Zhang LM; Zhang ZF; Sun BS
    World J Surg; 2012 Feb; 36(2):455-62. PubMed ID: 22187129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of postoperative radiotherapy on the survival of patients with stage III non-small cell lung cancer: A CONSORT-compliant analysis using the SEER database.
    Wu K; Peng W; Shuai Z; Peng X; Liu H; Zhang S
    Medicine (Baltimore); 2023 Jun; 102(24):e34015. PubMed ID: 37327271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of lymph node ratio on survival in non-small-cell lung cancer.
    Sezen CB; Kalafat CE; Doğru MV; Aker C; Erdogu V; Saydam O; Metin M
    Acta Chir Belg; 2023 Feb; 123(1):36-42. PubMed ID: 34006183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.